Expert Review of Anti-Infective Therapy

Papers
(The TQCC of Expert Review of Anti-Infective Therapy is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis116
Challenges in preserving antibiotic effectiveness: time for a novel approach87
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex57
Neonatal ocular prophylaxis in the United States: is it still necessary?53
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a52
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future47
Visceral leishmaniasis elimination in India: progress and the road ahead47
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review41
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin39
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies37
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia36
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR72035
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines34
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria34
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies33
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’32
Reemergence of monkeypox: prevention and management31
Difficile to treat: advanced management strategies in difficult to treat Clostridioides difficile infections31
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?30
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges29
Current status of immunomodulatory therapies in adult sepsis patients: where do we stand?27
Can Saccharomyces cerevisiae be used as a therapeutic agent for vulvovaginal candidiasis?26
Treatment of vaginitis caused by non-albicans Candida species26
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis26
Identifying predictors of treatment failure with community-acquired pneumonia: an update26
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis25
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections24
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China23
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?22
Advances and controversies in the diagnosis and management of neurocysticercosis: a clinical perspective21
Treatment of pulmonary mucormycosis: current concepts21
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline21
Diagnostic and clinical management of Candida auris infections in immunocompromised patients20
Advances in therapeutic strategies against Mycobacterium marinum infection20
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin20
Phage- and enzybiotic-coated urinary catheters to prevent recurrent multidrug-resistant bacterial infections20
Theranostic nanomaterials for scalp and hair fungal infections: advancing diagnosis and treatment amidst challenges19
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases19
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-1919
Diagnostic and management strategies for chronic hepatitis E infection19
One health and resistant fungi: a challenging balancing act between food security and patient survival19
Predicting the limit to ceftriaxone’s use in gonorrhea treatment: impending resistance and logistical challenges19
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance19
Real-world effectiveness and tolerability of post solid organ transplant patients with CMV switching from valganciclovir treatment to maribavir: analysis using lab-linked claims data in the United Sta18
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases18
Updates on Candida albicans infections: pathogenesis, resistance, and emerging nanopharmaceutical strategies17
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development17
Infliximab as a potential treatment for COVID-1917
Analysis of bacterial spectrum and construction of a predictive model for postoperative sepsis in patients with upper urinary calculi and positive urinary cultures16
Correction16
Statement of Retraction16
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers?16
Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase production: a systemat16
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections15
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India15
Risk of HIV viral rebound after SARS-CoV-2 infection among people living with HIV on antiretroviral therapy: a retrospective matched cohort study15
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae15
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential15
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches15
Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury14
The serological dilemma: rethinking syphilis treatment evaluation14
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)14
Inhibiting horizontal gene transfer to contain antimicrobial resistance: conjugation and plasmid maintenance as druggable targets13
The evolving debate around screening for Chlamydia trachomatis13
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana13
Diagnosing fungal infections in clinical practice: a narrative review13
In vitro and in vivo activity of meropenem+avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae13
Monoclonal antibodies for the treatment of COVID-19 infection in children13
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae12
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas12
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study12
An overview of potential combination therapies with ceftriaxone as a treatment for gonorrhoea12
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision11
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review11
Disruptive innovation in antibiotic development: a vision for lysins11
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection11
Targeted screening for HTLV-1 infection in endemic and non-endemic regions: a global public health priority11
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations11
Challenges associated with pertussis detection, monitoring, and vaccination in adults11
Precision antibiotic treatment in intensive care unit-acquired lower respiratory tract infections (ICU-LRTIs): contemporary concepts and future directions11
How can we tackle the overuse of antibiotics in low- and middle-income countries?11
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?11
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers11
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients10
Now that griseofulvin is not available, what to do with tinea capitis treatments?10
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies10
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials10
Unmet targets: evaluating vancomycin use and predictive factors of target attainment in hemodialysis patients10
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review10
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents10
Women trailblazers shaping the global future of antimicrobial stewardship and antimicrobial resistance10
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals10
A 96-week efficacy and safety of BIC/FTC/TAF in ART-naïve HIV-1 infected patients in China10
New insights into the treatment of acute otitis media10
How do we best manage Clostridioides difficle infections in the elderly?10
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?10
Comparison of clinical outcomes of antibiotics used for Staphylococcus aureus bacteremia in pediatric patients10
Gram-positive infections in special populations. Expert view on the role of dalbavancin10
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis10
Tocilizumab for the treatment of COVID-1910
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America10
Diagnosis of urinary tract infections in the pediatric population – current practices, advances and progress9
Artificial intelligence and prescription of antibiotic therapy: present and future9
Efficacy and safety of gepotidacin versus standard of-care antibiotics for the treatment of uncomplicated urogenital infections in adults and adolescents: a systematic review and meta-analysis9
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials9
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-199
Global importance of new treatment strategies to efforts to control hepatitis B virus9
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo9
Comparative effectiveness of ceftaroline plus vancomycin or daptomycin versus vancomycin or daptomycin monotherapy for MRSA bacteremia: an updated systematic review and meta-analysis9
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t9
Efficacy and safety of eravacycline (ERV) in treating infections caused by Gram-negative pathogens: a systematic review and meta-analysis9
0.10072803497314